Durolane 60 MG/3 ML syringe 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFBQ7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,472
Award facts
- Contract value 100% obligated
- $17,472.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a $17,472 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Durolane 60 mg/3 ml syringes. The contract, awarded on December 15, 2025, with an ultimate completion date of January 7, 2026, is issued under a firm fixed-price arrangement with no set-aside designation, indicating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is performing the work at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription medications, biologics, and medical consumables. As a single-award prime vendor contractor under this strategic program, DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, supporting recurring medical supply needs across military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FFBQ7?
SPE2DR26FFBQ7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FFBQ7 worth?
The government has obligated $17,472 on SPE2DR26FFBQ7.
Is contract SPE2DR26FFBQ7 an order under another contract?
Yes. SPE2DR26FFBQ7 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBQ7 competed?
The extent of competition for SPE2DR26FFBQ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award